137 related articles for article (PubMed ID: 17509106)
1. Neurotoxicity upon infusion of dimethylsulfoxide-cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease.
Mueller LP; Theurich S; Christopeit M; Grothe W; Muetherig A; Weber T; Guenther S; Behre G
Eur J Haematol; 2007 Jun; 78(6):527-31. PubMed ID: 17509106
[TBL] [Abstract][Full Text] [Related]
2. Severe central nervous system toxicity associated with the infusion of cryopreserved PBSC components.
Rowley S; MacLeod B; Heimfeld S; Holmberg L; Bensinger W
Cytotherapy; 1999; 1(4):311-7. PubMed ID: 20440908
[TBL] [Abstract][Full Text] [Related]
3. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.
Ozdemir E; Akgedik K; Akdogan S; Kansu E
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066
[TBL] [Abstract][Full Text] [Related]
4. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
[TBL] [Abstract][Full Text] [Related]
5. Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells.
Otrock ZK; Beydoun A; Barada WM; Masroujeh R; Hourani R; Bazarbachi A
Haematologica; 2008 Mar; 93(3):e36-7. PubMed ID: 18310533
[TBL] [Abstract][Full Text] [Related]
6. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells.
Hoyt R; Szer J; Grigg A
Bone Marrow Transplant; 2000 Jun; 25(12):1285-7. PubMed ID: 10871734
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
[TBL] [Abstract][Full Text] [Related]
8. Clinical side effects during peripheral blood progenitor cell infusion.
Donmez A; Tombuloglu M; Gungor A; Soyer N; Saydam G; Cagirgan S
Transfus Apher Sci; 2007 Feb; 36(1):95-101. PubMed ID: 17236813
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients -- impact of cryopreservation with dimethylsulfoxide.
Horacek JM; Jebavy L; Jakl M; Zak P; Mericka P; Maly J
Exp Oncol; 2009 Jun; 31(2):121-2. PubMed ID: 19550404
[TBL] [Abstract][Full Text] [Related]
10. [Clinical toxicity at the infusion of cryopreserved and thawed peripheral blood stem cell grafts in children].
Okamoto Y; Takaue Y; Yasutomo K; Saito S; Hirao A; Matsunaga K; Abe T; Shimizu T; Sato J; Watanabe T
Rinsho Ketsueki; 1992 Mar; 33(3):317-21. PubMed ID: 1578635
[TBL] [Abstract][Full Text] [Related]
11. Post-thaw removal of DMSO does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockade.
Rowley SD; Feng Z; Yadock D; Holmberg L; Macleod B; Heimfeld S
Cytotherapy; 1999; 1(6):439-46. PubMed ID: 20426544
[TBL] [Abstract][Full Text] [Related]
12. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
13. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres.
Windrum P; Morris TC; Drake MB; Niederwieser D; Ruutu T;
Bone Marrow Transplant; 2005 Oct; 36(7):601-3. PubMed ID: 16044141
[TBL] [Abstract][Full Text] [Related]
14. Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide.
Abrahamsen JF; Rusten L; Bakken AM; Bruserud Ø
Transfusion; 2004 May; 44(5):785-9. PubMed ID: 15104663
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing.
Calmels B; Houzé P; Hengesse JC; Ducrot T; Malenfant C; Chabannon C
Bone Marrow Transplant; 2003 May; 31(9):823-8. PubMed ID: 12732892
[TBL] [Abstract][Full Text] [Related]
16. The occurrence of adverse events during the infusion of autologous peripheral blood stem cells is related to the number of granulocytes in the leukapheresis product.
Cordoba R; Arrieta R; Kerguelen A; Hernandez-Navarro F
Bone Marrow Transplant; 2007 Dec; 40(11):1063-7. PubMed ID: 17906706
[TBL] [Abstract][Full Text] [Related]
17. Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients.
Martino M; Morabito F; Messina G; Irrera G; Pucci G; Iacopino P
Haematologica; 1996; 81(1):59-61. PubMed ID: 8900855
[TBL] [Abstract][Full Text] [Related]
18. [Hemolytic uremic syndrome-like episode following nonmyeloablative hematopoietic stem cell transplantation in a patient with chronic myeloid leukemia].
Takahashi N; Miura I; Kume M; Kawabata Y; Hirokawa M; Sawada K
Rinsho Ketsueki; 2003 Jun; 44(6):391-5. PubMed ID: 12884818
[TBL] [Abstract][Full Text] [Related]
19. Neurotoxicity Associated With Dimethyl Sulfoxide Used in Allogeneic Stem Cell Transplantation.
Ataseven E; Tüfekçi Ö; Yilmaz Ş; Güleryüz H; Ören H
J Pediatr Hematol Oncol; 2017 Jul; 39(5):e297-e299. PubMed ID: 28121745
[TBL] [Abstract][Full Text] [Related]
20. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis.
Benekli M; Anderson B; Wentling D; Bernstein S; Czuczman M; McCarthy P
Bone Marrow Transplant; 2000 Jun; 25(12):1299-301. PubMed ID: 10871736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
